AVNS
AVANOS MEDICAL, INC.
AVANOS MEDICAL, INC. (AVNS) has 17 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: Jul 28, 2026.
- Industry:Medical - Devices
- CEO:David C. Pacitti
- Employees:2,287
- HQ:Alpharetta, GA, US
- IPO:2014-10-21
No open-market insider trades for AVNS (AVANOS MEDICAL, INC.) in the last 365 days.
Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.
Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.
Related companies
AVANOS MEDICAL, INC. is in the Manufacturing sector.